Using Neural Networks to Predict Multidrug-resistant Organisms
OCT 02, 2017 | CONTAGION® EDITORIAL STAFF
Alan Gross, PharmD, BCPS-AQID, Clinical Assistant Professor, Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, explains how a neural network might help identify patients who are at increased risk for multidrug-resistant organisms. Dr. Gross shares that through the use of more electronic health records, along with the integration of neural networks and other clinical decision support software, it will be easier to identify patients at high risk of having a resistant pathogen. However, Dr. Gross points out that this is an area that’s still in development.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512